Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer

A major problem of colorectal cancer (CRC) targeted therapies is relapse caused by drug resistance. In most cases of CRC, patients develop resistance to anticancer drugs. Cetuximab does not show many of the side effects of other anticancer drugs and improves the survival of patients with metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Seong Hye, Jo, Min Jee, Kim, Bo Ram, Jeong, Yoon A, Na, Yoo Jin, Kim, Jung Lim, Jeong, Soyeon, Yun, Hye Kyeong, Kim, Dae Yeong, Kim, Bu Gyeom, Kang, Sang Hee, Oh, Sang Cheul, Lee, Dae-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531304/
https://www.ncbi.nlm.nih.gov/pubmed/31149041
http://dx.doi.org/10.7150/thno.30678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531304/
https://www.ncbi.nlm.nih.gov/pubmed/31149041
http://dx.doi.org/10.7150/thno.30678

Ejemplares similares